| abstract |
Abstract A topical, cosmetic or pharmaceutical composition comprising one or more pharmaceutically or cosmetically 5 acceptable excipients and a combination of solar filters only consisting of 3 or 4 solar filters comprising: * one or two solar UVA filters to obtain a critical wavelength > 370 nm, chosen from among: iv. 5,6,5,6-tetraphenyl-3,3'-(1,4-phenylene) 0 bis[1,2,4]triazine, v. 1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino) 2-hydroxybenzoyl]phenyl]-methanone, and vi. Butyl Methoxydibenzoylmethane (BMDBM), in a quantity less than 2% by weight with regard to the total weight 5 of said composition, and " 2,4-Bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4 methoxyphenyl)-1,3,5-triazine (BEMT), and " one or two solar UVB filters, chosen from among the following compounds: 0 - diethylhexyl butamido triazone, - ethylhexyl triazone, - tris-biphenyl triazine, in a quantity between 3% and 7% by weight with regard to the total weight of the composition 25 - ethylhexyl salicylate, - phenylbenzimidazole sulfonic acid, and - TiO 2 , with the proviso that the solar filters do not include octocrylene, para-aminobenzoic acid (PABA) and ethylhexyl 30 methoxycinnamate. |